Research progress of drugs commonly used to anti-rheumatoid arthritis.
- Author:
Li-Qun CHI
;
Bin ZHOU
;
Wen-Yuan GAO
;
Zhen LIU
- Publication Type:Journal Article
- MeSH:
Animals;
Arthritis, Rheumatoid;
drug therapy;
Biological Factors;
adverse effects;
therapeutic use;
Drug Discovery;
methods;
Glucocorticoids;
adverse effects;
therapeutic use;
Humans;
Medicine, Chinese Traditional;
adverse effects
- From:
China Journal of Chinese Materia Medica
2014;39(15):2851-2858
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatoid arthritis (RA) is a kind of chronic, progressive, multiple, invasive autoimmune disease with two chief cclinical manifestations arthrosynovitis and ex-arthrosis, easy to occur in middle-aged women, also occur in children and the elderly, is characterized by progressive and break out repeatedly. RA pathogenesis is complex, there is no special treatment, used in treatment of R drug varied, new drugs and new therapies also emerge in endlessly, main including non-steroidal anti-inflammatory drugs (NSAIDs), slow action anti-rheumatism medicine (SAARDs), glucocorticoids (GCs), biological agent, traditional Chinese medicine and traditional Chinese medicine preparations, domestic market for rheumatoid main drug treatment are NSAIDs, SAARDs, GCs, traditional Chinese medicine and traditional Chinese medicine preparations. Traditional Chinese medicine and traditional Chinese medi- cine preparations for the treatment of RA have its unique advantages, show the characteristics of overall adjustment, multi-level and multiple targets, and also can alleviate and against side effects of western medicine. In recent years, more and more get people's atten- tion. This paper reviewed the research progress and treatment features of commonly used therapeutic agents for the treatment of RA in recent years, which provides reference and basis for future medicine anti-RA.
